EP 3814377 A2 20210505 - ANTI-SIRP-BETA1 ANTIBODIES AND METHODS OF USE THEREOF
Title (en)
ANTI-SIRP-BETA1 ANTIBODIES AND METHODS OF USE THEREOF
Title (de)
ANTI-SIRP-BETA1-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON
Title (fr)
ANTICORPS ANTI-SIRP-BÊTA1 ET PROCÉDÉS D'UTILISATION ASSOCIÉS
Publication
Application
Priority
- US 201862691913 P 20180629
- US 2019039757 W 20190628
Abstract (en)
[origin: WO2020006374A2] The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPβ1 polypeptide, e.g., a human SIRPβ1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
IPC 8 full level
C07K 16/28 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP IL KR US)
A61P 25/00 (2017.12 - KR); A61P 25/28 (2017.12 - EP IL); A61P 35/00 (2017.12 - EP IL KR US); C07K 16/2803 (2013.01 - EP IL KR US); A61K 2039/505 (2013.01 - EP IL KR US); A61K 2039/507 (2013.01 - EP IL KR US); C07K 2317/21 (2013.01 - EP IL KR); C07K 2317/31 (2013.01 - US); C07K 2317/33 (2013.01 - EP IL KR US); C07K 2317/565 (2013.01 - KR); C07K 2317/73 (2013.01 - EP IL KR); C07K 2317/75 (2013.01 - EP IL US); C07K 2317/92 (2013.01 - EP IL KR US)
Citation (search report)
See references of WO 2020006374A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020006374 A2 20200102; WO 2020006374 A3 20200220; AU 2019293589 A1 20210121; BR 112020026819 A2 20210420; CA 3099176 A1 20200102; CN 112384532 A 20210219; EA 202190138 A1 20210527; EP 3814377 A2 20210505; IL 279648 A 20210301; JP 2021529520 A 20211104; KR 20210025614 A 20210309; MA 53015 A 20210505; MX 2020013324 A 20210512; SG 11202010990T A 20201230; US 2021277113 A1 20210909
DOCDB simple family (application)
US 2019039757 W 20190628; AU 2019293589 A 20190628; BR 112020026819 A 20190628; CA 3099176 A 20190628; CN 201980040821 A 20190628; EA 202190138 A 20190628; EP 19744960 A 20190628; IL 27964820 A 20201221; JP 2020572914 A 20190628; KR 20217002521 A 20190628; MA 53015 A 20190628; MX 2020013324 A 20190628; SG 11202010990T A 20190628; US 201917256508 A 20190628